跳至主要内容
临床试验/CTRI/2009/091/000813
CTRI/2009/091/000813已完成3 期

A randomized, double blind, comparative, parallel-group clinical trial to evaluate the efficacy and safety of a combination of trypsin-chymotrypsin enzymes and diclofenac (TCD) in comparison to diclofenac alone in the management of inflammation due to soft tissue injuries

Elder Pharmaceuticals Ltd.,C-9, Dalia Industrial Estate, Veera Desai Road, Off New Link Road,Andheri (W), Mumbai ? 53.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Adult patients aged between 18 and 65 years with soft tissue injuries like sprains, strains, stress injuries, ecchymosis, hematomas and lacerations seen within 24 hours of the injury
  • 2)Patients aged between 18 and 65 years.
  • 3)Patients who have given their written informed consent
  • 4)Patients of childbearing years who are using appropriate contraceptive methods for 3 weeks prior to the study and throughout the duration of the study.
  • The following patients may also be included:
  • 1. Clean Lacerated Wounds (non infected) requiring suturing.
  • 2.Patients with healed fractures more than 3 months old

排除标准

  • 1)Any long standing/ chronic inflammatory condition like Rheumatoid Arthritis, Osteoarthritis or Spondylitis where the patient has been on long term NSAIDs, Anti-Inflammatory drugs or Analgesics.
  • 2)Infected wounds, Tissue abscesses and Cellulitis
  • 3)Patients with Fracture if less than 3 months old.
  • 4)Post operative cases
  • 5)Patients who have Diabetes/ Raised Blood Sugar
  • 6)Pregnant or breast-feeding women.
  • 7)Patients who are simultaneously participating in another clinical trial with an unlicensed drug or who have done so within a one month period.
  • 8)Patients with a known hypersensitivity to TC or Diclofenac

研究者

发起方
Elder Pharmaceuticals Ltd.,C-9, Dalia Industrial Estate, Veera Desai Road, Off New Link Road,Andheri (W), Mumbai ? 53.

相似试验